These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34244299)

  • 1. Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity.
    Sakemura R; Bansal A; Siegler EL; Hefazi M; Yang N; Khadka RH; Newsom AN; Hansen MJ; Cox MJ; Manriquez Roman C; Schick KJ; Can I; Tapper EE; Nevala WK; Adada MM; Bezerra ED; Kankeu Fonkoua LA; Horvei P; Ruff MW; Parikh SA; Pandey MK; DeGrado TR; Suksanpaisan L; Kay NE; Peng KW; Russell SJ; Kenderian SS
    Cancer Immunol Res; 2021 Sep; 9(9):1035-1046. PubMed ID: 34244299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Jiang H; DeGrado TR
    Theranostics; 2018; 8(14):3918-3931. PubMed ID: 30083270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of [
    Niu M; Qin J; Wang L; He Y; Tian C; Chen Y; Huang P; Peng Z
    Mol Imaging; 2022; 2022():2679260. PubMed ID: 35330799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging CAR-NK cells targeted to HER2 ovarian cancer with human sodium-iodide symporter-based positron emission tomography.
    Shalaby N; Xia Y; Kelly JJ; Sanchez-Pupo R; Martinez F; Fox MS; Thiessen JD; Hicks JW; Scholl TJ; Ronald JA
    Eur J Nucl Med Mol Imaging; 2024 Sep; 51(11):3176-3190. PubMed ID: 38722382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatiotemporal PET Imaging Reveals Differences in CAR-T Tumor Retention in Triple-Negative Breast Cancer Models.
    Volpe A; Lang C; Lim L; Man F; Kurtys E; Ashmore-Harris C; Johnson P; Skourti E; de Rosales RTM; Fruhwirth GO
    Mol Ther; 2020 Oct; 28(10):2271-2285. PubMed ID: 32645298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography.
    Sakemura R; Cox MJ; Bansal A; Roman CM; Hefazi M; Vernon CJ; Glynn DL; Pandey MK; DeGrado TR; Siegler EL; Kenderian SS
    J Vis Exp; 2022 Feb; (180):. PubMed ID: 35253798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholesterol Esterification Enzyme Inhibition Enhances Antitumor Effects of Human Chimeric Antigen Receptors Modified T Cells.
    Zhao L; Li J; Liu Y; Kang L; Chen H; Jin Y; Zhao F; Feng J; Fang C; Zhu B; Ding S; Yu L; Wei Y; Zhou J
    J Immunother; 2018; 41(2):45-52. PubMed ID: 29252915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical study on treatment of CD19-directed chimeric antigen receptor-modified T cells in a case of refractory Richter syndrome.
    Xia L; Wang Y; Li T; Hu X; Chen Q; Liu L; Jiang B; Li C; Wang H; Wang S; Yang G; Bao Y
    Cancer Med; 2019 Jun; 8(6):2930-2941. PubMed ID: 31050207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of failure of chimeric antigen receptor T-cell therapy.
    Li X; Chen W
    Curr Opin Hematol; 2019 Nov; 26(6):427-433. PubMed ID: 31577606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 18F-Tetrafluoroborate via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor Model.
    Jiang H; Bansal A; Pandey MK; Peng KW; Suksanpaisan L; Russell SJ; DeGrado TR
    J Nucl Med; 2016 Sep; 57(9):1454-9. PubMed ID: 27103021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intention to treat versus modified intention-to-treat analysis in B-cell maturation antigen and CD19 chimeric antigen receptor trials: A systematic review and meta-analysis.
    Mohyuddin GR; Atieh T; Ahmed N; Sborov D; McClune B; Abdallah AO; Goodman AM; Aziz M; Allen I; Prasad V
    Eur J Cancer; 2021 Oct; 156():164-174. PubMed ID: 34454318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-derived Xenograft Mouse Model.
    Manriquez Roman C; Sakemura RL; Kimball BL; Jin F; Khadka RH; Adada MM; Siegler EL; Johnson AJ; Kenderian SS
    J Vis Exp; 2023 Feb; (192):. PubMed ID: 36847405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell maturation antigen-specific CAR T cells are clinically active in multiple myeloma.
    Cohen AD; Garfall AL; Stadtmauer EA; Melenhorst JJ; Lacey SF; Lancaster E; Vogl DT; Weiss BM; Dengel K; Nelson A; Plesa G; Chen F; Davis MM; Hwang WT; Young RM; Brogdon JL; Isaacs R; Pruteanu-Malinici I; Siegel DL; Levine BL; June CH; Milone MC
    J Clin Invest; 2019 Mar; 129(6):2210-2221. PubMed ID: 30896447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of
    Jiang H; Bansal A; Goyal R; Peng KW; Russell SJ; DeGrado TR
    Bioorg Med Chem; 2018 Jan; 26(1):225-231. PubMed ID: 29198608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cryopreservation on chimeric antigen receptor T cell functions.
    Xu H; Cao W; Huang L; Xiao M; Cao Y; Zhao L; Wang N; Zhou J
    Cryobiology; 2018 Aug; 83():40-47. PubMed ID: 29908946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rational design of a trimeric APRIL-based CAR-binding domain enables efficient targeting of multiple myeloma.
    Schmidts A; Ormhøj M; Choi BD; Taylor AO; Bouffard AA; Scarfò I; Larson RC; Frigault MJ; Gallagher K; Castano AP; Riley LS; Cabral ML; Boroughs AC; Velasco Cárdenas RM; Schamel W; Zhou J; Mackay S; Tai YT; Anderson KC; Maus MV
    Blood Adv; 2019 Nov; 3(21):3248-3260. PubMed ID: 31698455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenografts.
    Sterner RM; Sakemura R; Cox MJ; Yang N; Khadka RH; Forsman CL; Hansen MJ; Jin F; Ayasoufi K; Hefazi M; Schick KJ; Walters DK; Ahmed O; Chappell D; Sahmoud T; Durrant C; Nevala WK; Patnaik MM; Pease LR; Hedin KE; Kay NE; Johnson AJ; Kenderian SS
    Blood; 2019 Feb; 133(7):697-709. PubMed ID: 30463995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of sodium iodide symporter co-expression on proliferation and cytotoxic activity of chimeric antigen receptor T cells
    Tian C; Huang P; He Y; Wang L; Peng Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Jul; 42(7):1062-1068. PubMed ID: 35869771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-CD123 chimeric antigen receptor T-cells (CART): an evolving treatment strategy for hematological malignancies, and a potential ace-in-the-hole against antigen-negative relapse.
    Cummins KD; Gill S
    Leuk Lymphoma; 2018 Jul; 59(7):1539-1553. PubMed ID: 28901790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced noninvasive imaging of oncology models using the NIS reporter gene and bioluminescence imaging.
    Vandergaast R; Khongwichit S; Jiang H; DeGrado TR; Peng KW; Smith DR; Russell SJ; Suksanpaisan L
    Cancer Gene Ther; 2020 Apr; 27(3-4):179-188. PubMed ID: 30674994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.